[Association between paraoxonase-1 and paraoxonase-2 polymorphisms and the risk of acute myocardial infarction].
暂无分享,去创建一个
J. Marrugat | M. Sentí | M. Tomás | J. Vila | J. Sala | M. Guxens | M. Fiol | E. Aldasoro | A. Segura | G. Vega | R. Elosúa | M. Fullana | M. de la Rica
[1] L. Whalley,et al. Paraoxonase gene polymorphisms and haplotype analysis in a stroke population , 2006, BMC Medical Genetics.
[2] Dan S. Tawfik,et al. The Catalytic Histidine Dyad of High Density Lipoprotein-associated Serum Paraoxonase-1 (PON1) Is Essential for PON1-mediated Inhibition of Low Density Lipoprotein Oxidation and Stimulation of Macrophage Cholesterol Efflux* , 2006, Journal of Biological Chemistry.
[3] M. Aviram,et al. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. , 2004, Free radical biology & medicine.
[4] J. Marrugat,et al. Función antioxidante de las lipoproteínas de alta densidad: un nuevo paradigma en la arteriosclerosis , 2004 .
[5] Dan S. Tawfik,et al. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes , 2004, Nature Structural &Molecular Biology.
[6] J. Danesh,et al. Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: meta-analysis of 43 studies , 2004, The Lancet.
[7] E. Trabetti,et al. Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction , 2004, European journal of clinical investigation.
[8] E. Hawe,et al. Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II. , 2003, Biochimica et biophysica acta.
[9] Shu Wen,et al. [The association of paraoxonase 2 gene C311S variant with ischemic stroke in Chinese type 2 diabetes mellitus patients]. , 2003, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.
[10] P. Mecocci,et al. Genetic factors associated with the absence of atherosclerosis in octogenarians. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.
[11] K. Donaghue,et al. Paraoxonase gene cluster is a genetic marker for early microvascular complications in Type 1 diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[12] S. Reddy,et al. Paraoxonase-2 Is a Ubiquitously Expressed Protein with Antioxidant Properties and Is Capable of Preventing Cell-mediated Oxidative Modification of Low Density Lipoprotein* , 2001, The Journal of Biological Chemistry.
[13] P. Durrington,et al. Paraoxonase Status in Coronary Heart Disease: Are Activity and Concentration More Important Than Genotype? , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[14] A. Gotto,et al. A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin. , 2001, Atherosclerosis.
[15] R. Elosua,et al. Validation of the Minnesota Leisure Time Physical Activity Questionnaire In Spanish Women. Investigators of the MARATDON Group. , 2000, Medicine and science in sports and exercise.
[16] M. Aviram,et al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. , 2000, Circulation.
[17] P. McNamee,et al. Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients. , 1999, Kidney international.
[18] D. Shih,et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.
[19] S. Scherer,et al. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. , 1998, Gene.
[20] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[21] Alan D. Lopez,et al. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.
[22] T. Suehiro,et al. Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease. , 1996, International journal of cardiology.
[23] H. Tunstall-Pedoe,et al. Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.
[24] R. Elosua,et al. Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men. The MARATHOM Investigators. , 1994, American journal of epidemiology.
[25] C. Abbott,et al. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. , 1993, Atherosclerosis.
[26] S. Adkins,et al. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. , 1993, American journal of human genetics.
[27] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[28] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[29] S. Reis,et al. Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. , 2003, American journal of human genetics.
[30] J. Marrugat,et al. Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators. , 2000, European heart journal.
[31] P. Moulin,et al. Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-->R genetic polymorphism. , 1999, Journal of lipid research.
[32] D. Sanghera,et al. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. , 1998, American journal of human genetics.
[33] D. Adler,et al. The molecular basis of the human serum paraoxonase activity polymorphism , 1993, Nature Genetics.